Toxicological assessment of polyhexamethylene biguanide for water treatment

Open access


Polyhexamethylene biguanide (PHMB) is an antiseptic with antiviral and antibacterial properties used in a variety of products including wound care dressings, contact lens cleaning solutions, perioperative cleansing products, and swimming pool cleaners. There are regulatory concerns with regard to its safety in humans for water treatment. We decided to assess the safety of this chemical in Sprague-Dawley rats. PHMB was administered in a single dose by gavage via a stomach tube as per the manufacturer’s instruction within a dose range of 2 mg/kg to 40 mg/kg. Subchronic toxicity studies were also conducted at doses of 2 mg/kg, 8 mg/kg and 32 mg/kg body weight and hematological, biochemical and histopathological findings of the major organs were assessed. Administration of a dose of 25.6 mg/kg, i.e. 1.6 mL of 0.4% PHMB solution (equivalent to 6.4×103 mg/L of 0.1% solution) resulted in 50% mortality. Histopathological analysis in the acute toxicity studies showed that no histopathological lesions were observed in the heart and kidney samples but 30% of the animals had mild hydropic changes in zone 1 of their liver samples, while at a dosage of 32 mg/kg in the subchronic toxicity studies, 50% of the animals showed either mild hepatocyte cytolysis with or without lymphocyte infiltration and feathery degeneration. Lymphocyte infiltration was, for the first time, observed in one heart sample, whereas one kidney sample showed mild tubular damage. The acute studies showed that the median lethal dose (LD50) is 25.6 mg/kg (LC50 of 1.6 mL of 0.4% PHMB. Subchronic toxicological studies also revealed few deleterious effects on the internal organs examined, as seen from the results of the biochemical parameters evaluated. These results have implications for the use of PHMB to make water potable.

Arneson W, Brickell J. (2007). Assessment of liver function. In Clinical Chemistry: A laboratory Perspective. 1st ed. Philadelphia: F.A. Davis, Davis Company pp. 233–66.

Asiedu-Gyekye IJ, Seidu MA, Awortwe C, Nyarko AK. (2014). Preliminary Safety assessment of polyhexamethylene guanidine hydrochloride. Int J Toxicol 33(6): 523–31.

Broxton P, Woodcock PM, Gilbert P. (1984). Binding of some polyhexamethylene biguanides to the cell envelope of Escherichia coli ATCC 8739. Microbios 41(163): 15–22.

Broxton P, Woodcock PM, Heatley F, Gilbert P. (1984). Interaction of some polyhexamethylene biguanides and membrane phospholipids in Escherichia coli. J Appl Bacteriol 57(1): 115–124.

Burger RM, Franco RJ, Drlica K. (1994). Killing Acanthamoebae with polyaminopropyl biguanide: quantitation and kinetics. Antimicrob Agents Chemother 38(4): 886–888.

European medicine guidelines (EMA). (2010). Guidelines on repeated dose toxicity, Committee for human medicinal products (CHMP).

Friedman LS, Keefe EB. (2012). A Handbook of Liver diseases, Approach to the patient with abnormal liver biochemical and function tests. Third Edition, pp. 20–50. ISBN-9781437717259.

Gilbert P, Pemberton D, Wilkinson DE. (1990). Synergism within polyhexamethylene biguanide biocide formulations. J Appl Bacteriol 69(4): 593–598.

Greaves P. (2007). Histopathology of preclinical toxicity studies: Interpretation and Relevance in Drug Safety Evaluation. 3rd ed. New York Academic Press.

Hala A, Mohammada, Mohammad T, Abdulfttaha, AO, Abdulazeza AM, Mahmoud RME. (2014). A study of electrolyte disturbances in patients with chronic stable asthma and with asthma attacks. Egyptian Journal of Chest Diseases and Tuberculosis 63(3): 529–534.

Hiti K, Walochnik J, Haller-Schober EM, Faschinger C, Aspock H. (2002). Viability of Acanthamoeba after exposure to a multipurpose disinfecting contact lens solution and two hydrogen peroxide systems. Br J Ophthalmol 86(2): 144–146.

Hughes R, Heaselgrave W, Kilvington S. (2003). Acanthamoeba polyphaga strain age and method of cyst production influence the observed efficacy of therapeutic agents and contact lens disinfectants. Antimicrob Agents Chemother 47(10): 3080–3084.

Ikeda T, Ledwith A, Bamford CH, Hann RA. (1984). Interaction of a polymeric biguanide biocide with phospholipids membranes. Biochem Biophys Acta 769(1): 57–66.

Jusmita D, Dilutpal S, Rahul S. (2015). Oxidative stress mediated electrolyte imbalance in 30 known cases of knee osteoarthritis patients: A clinical approach. Asian Journal of Medical Sciences 6(5): 26–30.

Kang S, Wanapat M, Phesatcha K, Norrapoke T. (2015). Effect of protein level and urea in concentrate mixture on feed intake and rumen fermentation in swamp buffaloes fed rice straw-based diet. Trop Anim Health Prod 47(4): 671–9.

Kim JY, Kim HH, Cho KH. (2013). Acute cardiovascular toxicity of sterilizers, PHMG, and PGH: severe inflammation in human cells and heart failure in zebrafish. Cardiovasc Toxicol 13(2): 148–60.

Kramer A, Roth B, Muller G, Rudolph P, Klocker N. (2004). Influence of the antiseptic agents polyhexanide and octenidine on FL cells and on healing of experimental superficial aseptic wounds in piglets. A double-blind, randomized, stratified, controlled, parallel-group study. Skin Pharmacol Physiol 17(3): 141–146.

Lee HB, Blaufox MD. (1985). Blood volume in the rat. The Journal of Nuclear Medicine 25: 72–76.

Lee JE, Oum BS, Choi HY, Yu HS, Lee JS. (2007). Cysticidal effect on acanthamoeba and toxicity on human keratocytes by polyhexamethylene biguanide and chlorhexidine. Cornea 26(6): 736–41.

Organization for Economic Cooperation and Development (OECD) Guidelines. (2001). Guidelines for Testing of Chemicals: Acute Oral Toxicity-fixed Dose Procedure, pp. 420.

Ostapenko YN, Brusin KM, Zobnin YV, Shchupak AY, Vishnevetskiy MK, Sentsov VG, Novikova OV, Alekseenko SA, Lebedko OA, Puchkov YB. (2011). Acute cholestatic liver injury caused by polyhexamethyleneguanidine hydrochloride admixed to ethyl alcohol. Crit Care Toxicol 49(6): 471–477.

Polat ZA, Walochnik J, Obwaller A, Vural A, Dursun A, Arici MK. (2013). Miltefosine and polyhexamethylene biguanide: a new drug combination for the treatment of Acanthamoeba keratitis. Clin Experiment Ophthalmol 42(2): 151–8.

Romanowski EG, Yates KA, O’Connor KE, Mah FS, Shanks RM, Kowalski RP. (2013). Evaluation of polyhexamethylene biguanide (PHMB) as a disinfectant for adenovirus. JAMA Ophthalmol 131(4): 495–8.

Schnuch A, Geier J, Uter W, Basketter DA, Jowsey IR. (2007). The biocide polyhexamethylene biguanide remains an uncommon contact allergen. Contact Dermatitis 56(4): 235–9.

Taconic Technical Library. (2003). Hematological Clinical Chemistry values Sprague-Dawley rats.

Welk A, Splieth CH, Schmidt-Martens G, Schwahn Ch, Kocher T, Kramer A, Rosin M. (2005). The effect of a polyhexamethylene biguanide mouth-rinse compared with a triclosan rinse and a chlorhexidine rinse on bacterial counts and 4-day plaque re-growth. J Clin Periodontol 32(5): 499–505.

WHO. (2000). General Guidelines for Methodologies on Research and Evaluation of Traditional Medicine, Geneva, pp.80.

Wright JB, Lam K, Olson ME, Burrell RE. (2003). Is antimicrobial efficacy sufficient? A question concerning the benefits of new dressings. Wounds 15(5): 133–142.

Interdisciplinary Toxicology

The Journal of Institute of Experimental Pharmacology of Slovak Academy of Sciences

Journal Information

CiteScore 2017: 2.36

SCImago Journal Rank (SJR) 2017: 0.580
Source Normalized Impact per Paper (SNIP) 2017: 1.134

Cited By


All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 282 247 12
PDF Downloads 146 136 7